期刊文献+

The Study of Early Application with Dixiong Decoction for Non-small Cell Lung Cancer to Decrease the Incidence and Severity of Radiation Pneumonitis: A Prospective, Randomized Clinical Trial 被引量:3

The Study of Early Application with Dixiong Decoction for Non-small Cell Lung Cancer to Decrease the Incidence and Severity of Radiation Pneumonitis: A Prospective, Randomized Clinical Trial
原文传递
导出
摘要 Objective: To evaluate the efficacy of compound Dixiong Decoction (地芎汤, a Chinese herbal decoction) on early prevention of radiation pneumonitis. Methods: Forty-six patients with non-small cell lung cancer who were planning to receive radiotherapy were randomly assigned to the treatment group treated with the compound Dixiong Decoction and the control group treated with a commonly used herbal decoction which has the effects of supplementing qi and nourishing yin, clearing heat and detoxifying at the time of radiotherapy. Primary measure was the incidence of radiation pneumonitis after radiotherapy. Secondary outcomes included Watters clinical radiographic physiologic (CRP) dyspnea score, the Radiation Therapy Oncology Group (RTOG) grading score, Karnofsky Performance Status (KPS) score, and the application of corticosteroids. Results: The incidence of radiation pneumonitis in the treatment group was 10.0%, while that in the control group was 26.3% (P=0.0032). The Watters CRP dyspnea score and RTOG grading score in the treatment group were significantly lower than those in the control group (P0.05). The KPS score in the treatment group was significantly higher than that in the control group (P0.01). The dosage of corticosteroids was smaller with a shorter duration of therapy in the treatment group than that in the control group. Conclusion: The early application of the Chinese herbal decoction compound Dixiong Decoction can decrease the incidence of radiation pneumonitis, reduce the injury of the lung, and improve the life quality of the patients. Objective: To evaluate the efficacy of compound Dixiong Decoction (地芎汤, a Chinese herbal decoction) on early prevention of radiation pneumonitis. Methods: Forty-six patients with non-small cell lung cancer who were planning to receive radiotherapy were randomly assigned to the treatment group treated with the compound Dixiong Decoction and the control group treated with a commonly used herbal decoction which has the effects of supplementing qi and nourishing yin, clearing heat and detoxifying at the time of radiotherapy. Primary measure was the incidence of radiation pneumonitis after radiotherapy. Secondary outcomes included Watters clinical radiographic physiologic (CRP) dyspnea score, the Radiation Therapy Oncology Group (RTOG) grading score, Karnofsky Performance Status (KPS) score, and the application of corticosteroids. Results: The incidence of radiation pneumonitis in the treatment group was 10.0%, while that in the control group was 26.3% (P=0.0032). The Watters CRP dyspnea score and RTOG grading score in the treatment group were significantly lower than those in the control group (P0.05). The KPS score in the treatment group was significantly higher than that in the control group (P0.01). The dosage of corticosteroids was smaller with a shorter duration of therapy in the treatment group than that in the control group. Conclusion: The early application of the Chinese herbal decoction compound Dixiong Decoction can decrease the incidence of radiation pneumonitis, reduce the injury of the lung, and improve the life quality of the patients.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2010年第5期411-416,共6页 中国结合医学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China(No. 30371826)
关键词 radiation pneumonitis complementary and alternative medicine Chinese herbal medicine clinical trial radiation pneumonitis complementary and alternative medicine Chinese herbal medicine clinical trial
  • 相关文献

参考文献3

二级参考文献21

  • 1刘莉,陆海,CE.Ruebe,Ch.Ruebe.人非小细胞肺癌细胞受照射后肿瘤坏死因子水平的变化[J].中华放射医学与防护杂志,2004,24(4):313-316. 被引量:5
  • 2焦红军.党参的药理作用及其临床应用[J].临床医学,2005,25(4):92-92. 被引量:171
  • 3杨明会,窦永起,刘哲峰.活血化瘀药物防治放射性肺损伤的实验研究[J].中国中西医结合杂志,2005,25(12):1096-1099. 被引量:30
  • 4欧阳策群,徐仁根,罗晓东,陶学伟,张新根.77例放射性肺损伤的X线诊断分析[J].实用癌症杂志,1996,11(3):196-198. 被引量:12
  • 5张兴权.黄芪抗流感病毒作用及诱生干扰素,促进免疫功能研究[J].中华微生物学及免疫学杂志,1984,5:91-3.
  • 6周际昌.实用肿瘤内科学[M].第2版,北京:人民卫生出版社,2005;266~267
  • 7Coker RK,Laurent GJ.Pulmonary fibrosis:cytokines in the balance.Eur Respir J 1998; 11(6):1218-1221.
  • 8Whittaker P,Kloner RA,Boughner DR,et al.Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light.Basic Res Cardiol 1994; 89(5):397-410.
  • 9Anscher MS,Vujaskovic Z.Mechanisms and potential targets for prevention and treatment of normal tissue injury after radiation therapy.Semin Oncol 2005; 32(2 Suppl 3):S86-S91.
  • 10Santana A,Saxena B,Noble NA,et al.Increased expression of transforming growth factor β (β1,β2,β3) in blemycin-induced pulmonary fibrosis.Am J Pespir Cell Mol Biol 1995; 13(1):34-44.

共引文献18

同被引文献26

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部